AZELASTINE

AZELASTINE was reported 18655 times

AZELASTINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRODUCT DELIVERY MECHANISM ISSUE 339 0.0630
1 PROLONGED EXPIRATION 14 0.0534
2 DEVICE PROGRAMMING ERROR 10 0.0315
3 INFUSION SITE DISCHARGE 55 0.0313
4 NASAL TURBINATE HYPERTROPHY 11 0.0292
5 INFUSION SITE BRUISING 53 0.0245
6 PRECANCEROUS CONDITION 16 0.0239
7 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 10 0.0234
8 SPUTUM PURULENT 15 0.0228
9 TREATMENT FAILURE 1879 0.0227
10 INFUSION SITE URTICARIA 15 0.0224
11 INFUSION SITE MASS 24 0.0221
12 INFUSION SITE HAEMORRHAGE 71 0.0216
13 INFUSION SITE PRURITUS 57 0.0180
14 INFUSION SITE DISCOMFORT 17 0.0164
15 INFUSION SITE SWELLING 99 0.0157
16 OBSTRUCTIVE SLEEP APNOEA SYNDROME 22 0.0151
17 ENDOCRINE OPHTHALMOPATHY 13 0.0150
18 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 15 0.0141
19 MULTIPLE ALLERGIES 110 0.0140
20 ALLERGIC SINUSITIS 12 0.0140
21 INFUSION SITE RASH 19 0.0138
22 INFUSION SITE DISCOLOURATION 12 0.0136
23 INFUSION SITE NODULE 13 0.0135
24 BONE DEMINERALISATION 14 0.0132
25 SEASONAL ALLERGY 180 0.0127
26 INFUSION SITE ERYTHEMA 107 0.0127
27 CHRONIC SINUSITIS 47 0.0125
28 PRODUCT LEAKAGE 69 0.0123
29 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 16 0.0118
30 PERIORBITAL PAIN 10 0.0118
31 NASAL SEPTUM DEVIATION 23 0.0118
32 MYCOTIC ALLERGY 10 0.0117
33 SINUSITIS BACTERIAL 12 0.0114
34 SINUS OPERATION 27 0.0113
35 DEVICE INFUSION ISSUE 28 0.0113
36 UPPER-AIRWAY COUGH SYNDROME 93 0.0113
37 INFUSION SITE IRRITATION 14 0.0109
38 IMPAIRED QUALITY OF LIFE 153 0.0106
39 INFUSION SITE WARMTH 13 0.0106
40 INFUSION SITE PAIN 135 0.0105
41 ACUTE SINUSITIS 18 0.0104
42 NASAL PRURITUS 13 0.0104
43 ALLERGY TO ANIMAL 11 0.0103
44 RHINITIS ALLERGIC 45 0.0101
45 POST-ACUTE COVID-19 SYNDROME 12 0.0097
46 MIDDLE EAR EFFUSION 21 0.0095
47 INFUSION SITE INDURATION 14 0.0094
48 CHORIORETINOPATHY 13 0.0091
49 PNEUMONIA PSEUDOMONAL 13 0.0085
50 NEPHROGENIC ANAEMIA 39 0.0084
51 PNEUMONIA INFLUENZAL 10 0.0084
52 RHINALGIA 23 0.0084
53 EYELID PAIN 17 0.0084
54 PRE-EXISTING CONDITION IMPROVED 52 0.0083
55 NASAL DISCOMFORT 66 0.0083
56 PRODUCT ADMINISTRATION INTERRUPTED 64 0.0081
57 CONJUNCTIVITIS ALLERGIC 12 0.0081
58 HELICOBACTER GASTRITIS 10 0.0081
59 SINUS DISORDER 157 0.0079
60 MAST CELL ACTIVATION SYNDROME 11 0.0078
61 SINUS PAIN 18 0.0077
62 SNORING 29 0.0077
63 PARANASAL SINUS DISCOMFORT 29 0.0077
64 ESSENTIAL HYPERTENSION 14 0.0076
65 PRODUCT CONTAINER SEAL ISSUE 13 0.0075
66 HYPOSMIA 11 0.0073
67 SINUSITIS 736 0.0072
68 INCORRECT DRUG ADMINISTRATION RATE 30 0.0070
69 NASAL POLYPS 33 0.0067
70 OXYGEN SATURATION ABNORMAL 19 0.0067
71 CYSTIC FIBROSIS 36 0.0065
72 HORDEOLUM 28 0.0065
73 HYPERPARATHYROIDISM SECONDARY 16 0.0064
74 PARANASAL SINUS HYPERSECRETION 24 0.0063
75 HYPERTONIC BLADDER 18 0.0062
76 INFUSION SITE EXTRAVASATION 38 0.0061
77 REBOUND ACID HYPERSECRETION 18 0.0059
78 EAR INFECTION 154 0.0058
79 ANIMAL BITE 15 0.0056
80 SINUS CONGESTION 75 0.0055
81 OBSTRUCTION 22 0.0055
82 ASTHMA 622 0.0055
83 FOOD ALLERGY 42 0.0054
84 BODY TEMPERATURE ABNORMAL 10 0.0054
85 NASAL DRYNESS 33 0.0053
86 INSURANCE ISSUE 80 0.0052
87 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 28 0.0051
88 DERMATITIS CONTACT 58 0.0051
89 INFUSION SITE REACTION 15 0.0050
90 OXYGEN CONSUMPTION INCREASED 12 0.0050
91 SNEEZING 111 0.0049
92 BLOOD IMMUNOGLOBULIN G DECREASED 12 0.0048
93 SLEEP APNOEA SYNDROME 91 0.0048
94 EAR SWELLING 10 0.0047
95 SINUS HEADACHE 28 0.0047
96 RHINITIS 38 0.0047
97 ATYPICAL PNEUMONIA 14 0.0047
98 PRODUCT ODOUR ABNORMAL 49 0.0047
99 REGURGITATION 16 0.0047
100 INTERVERTEBRAL DISC DEGENERATION 43 0.0046
101 SPUTUM DISCOLOURED 44 0.0046
102 UPPER RESPIRATORY TRACT INFECTION 213 0.0046
103 IMPAIRED GASTRIC EMPTYING 62 0.0045
104 TEMPOROMANDIBULAR JOINT SYNDROME 12 0.0045
105 BLEPHARITIS 18 0.0045
106 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 76 0.0045
107 HEREDITARY ANGIOEDEMA 48 0.0045
108 NASAL CONGESTION 257 0.0044
109 RESPIRATORY TRACT CONGESTION 69 0.0043
110 PHARYNGITIS STREPTOCOCCAL 47 0.0043
111 PULMONARY FUNCTION TEST DECREASED 19 0.0043
112 PRODUCTIVE COUGH 207 0.0043
113 VITAMIN D DEFICIENCY 42 0.0043
114 INFUSION SITE INFECTION 10 0.0043
115 THROAT CLEARING 16 0.0043
116 RESPIRATORY TRACT INFECTION 110 0.0042
117 BRONCHIECTASIS 28 0.0042
118 EYELID MARGIN CRUSTING 12 0.0041
119 PRODUCT DISTRIBUTION ISSUE 38 0.0041
120 SKIN DISCOMFORT 11 0.0041
121 BRONCHITIS 300 0.0040
122 PRODUCT TASTE ABNORMAL 54 0.0040
123 DEVICE DEFECTIVE 69 0.0040
124 ENURESIS 16 0.0040
125 MACULOPATHY 14 0.0039
126 HIATUS HERNIA 51 0.0039
127 SKIN WEEPING 14 0.0039
128 PERIPHERAL VENOUS DISEASE 16 0.0039
129 RESPIRATION ABNORMAL 27 0.0039
130 TRIGGER FINGER 16 0.0039
131 INCREASED TENDENCY TO BRUISE 36 0.0039
132 PERIORBITAL SWELLING 22 0.0039
133 DIASTOLIC DYSFUNCTION 12 0.0039
134 SPINAL STENOSIS 16 0.0039
135 OROPHARYNGEAL DISCOMFORT 35 0.0039
136 DRUG TITRATION ERROR 10 0.0039
137 LIPOMA 10 0.0039
138 RHINOVIRUS INFECTION 15 0.0039
139 PRODUCT CONTAINER ISSUE 33 0.0038
140 HEART VALVE INCOMPETENCE 11 0.0038
141 SECRETION DISCHARGE 48 0.0038
142 GASTROENTERITIS VIRAL 69 0.0038
143 DYSPNOEA AT REST 11 0.0038
144 GASTROINTESTINAL INFECTION 34 0.0038
145 EYE DISCHARGE 39 0.0037
146 EAR PRURITUS 13 0.0037
147 EAR DISCOMFORT 38 0.0037
148 RHINORRHOEA 239 0.0037
149 ERYTHEMA OF EYELID 20 0.0037
150 EAR CONGESTION 10 0.0037
151 DRY EYE 183 0.0037
152 SUSPECTED COVID-19 12 0.0036
153 PRODUCT DOSE OMISSION ISSUE 1053 0.0036
154 PLANTAR FASCIITIS 12 0.0036
155 EYE INFECTION 39 0.0035
156 BRAIN FOG 54 0.0034
157 WHEEZING 204 0.0034
158 MENISCUS INJURY 21 0.0034
159 DIZZINESS POSTURAL 33 0.0034
160 GLUCOSE TOLERANCE IMPAIRED 20 0.0034
161 APHONIA 47 0.0034
162 ROTATOR CUFF SYNDROME 43 0.0033
163 DEAFNESS NEUROSENSORY 11 0.0033
164 EYE PRURITUS 111 0.0033
165 EYE PAIN 186 0.0033
166 OCULAR DISCOMFORT 37 0.0033
167 EAR DISORDER 15 0.0033
168 THROAT IRRITATION 146 0.0033
169 NERVE COMPRESSION 30 0.0032
170 ARTHROPOD BITE 24 0.0032
171 PULMONARY MASS 48 0.0032
172 ROSACEA 15 0.0032
173 SKIN LACERATION 35 0.0032
174 RESPIRATORY SYNCYTIAL VIRUS INFECTION 28 0.0032
175 PRODUCT DOSE OMISSION IN ERROR 91 0.0032
176 SKIN ABRASION 15 0.0032
177 SPINAL OPERATION 39 0.0032
178 FOREIGN BODY SENSATION IN EYES 20 0.0031
179 GASTRIC INFECTION 12 0.0031
180 END STAGE RENAL DISEASE 57 0.0031
181 ORAL HERPES 61 0.0031
182 PRODUCT USE COMPLAINT 49 0.0031
183 DYSPNOEA EXERTIONAL 117 0.0031
184 JAW DISORDER 17 0.0031
185 VIRAL INFECTION 102 0.0031
186 TONGUE DISCOMFORT 13 0.0031
187 DECREASED ACTIVITY 33 0.0031
188 CHRONIC KIDNEY DISEASE 232 0.0031
189 DRY THROAT 31 0.0030
190 SKIN INFECTION 34 0.0030
191 SCLERODERMA 11 0.0030
192 EYE IRRITATION 174 0.0030
193 COUGH 847 0.0030
194 HYPERPHAGIA 12 0.0030
195 EOSINOPHIL COUNT INCREASED 25 0.0030
196 MIDDLE INSOMNIA 56 0.0030
197 SKIN SWELLING 26 0.0030
198 COVID-19 524 0.0030
199 WEIGHT FLUCTUATION 31 0.0030
200 TOOTH INFECTION 39 0.0030
201 EXOSTOSIS 27 0.0030
202 ILLNESS 303 0.0029
203 CHOKING SENSATION 16 0.0029
204 BODY HEIGHT DECREASED 31 0.0029
205 EAR PAIN 56 0.0029
206 DEVICE MALFUNCTION 202 0.0029
207 SWELLING OF EYELID 18 0.0029
208 PHARYNGEAL SWELLING 28 0.0029
209 OESOPHAGEAL ULCER 11 0.0029
210 CONJUNCTIVITIS 53 0.0029
211 SPINAL OSTEOARTHRITIS 25 0.0028
212 THERAPEUTIC PRODUCT INEFFECTIVE 11 0.0028
213 INTERVERTEBRAL DISC PROTRUSION 62 0.0028
214 POST PROCEDURAL INFECTION 23 0.0028
215 EXPOSURE VIA SKIN CONTACT 73 0.0028
216 COVID-19 PNEUMONIA 33 0.0028
217 TENSION HEADACHE 12 0.0028
218 TENDERNESS 29 0.0028
219 EMPHYSEMA 28 0.0028
220 SPONDYLITIS 10 0.0027
221 LACRIMATION INCREASED 83 0.0027
222 TRIGEMINAL NEURALGIA 11 0.0027
223 LIGAMENT SPRAIN 27 0.0027
224 GINGIVAL SWELLING 12 0.0027
225 VITAMIN B12 DEFICIENCY 11 0.0027
226 SPINAL FUSION SURGERY 11 0.0027
227 OSTEOPENIA 41 0.0027
228 FEELING DRUNK 20 0.0027
229 TONSILLITIS 14 0.0027
230 PSEUDOMONAS INFECTION 23 0.0027
231 CANDIDA INFECTION 45 0.0027
232 PHARYNGITIS 33 0.0027
233 SURGERY 155 0.0026
234 INJECTION SITE VESICLES 16 0.0026
235 ANOSMIA 38 0.0026
236 INABILITY TO AFFORD MEDICATION 26 0.0026
237 CONJUNCTIVAL HAEMORRHAGE 10 0.0026
238 FOOD POISONING 14 0.0026
239 LIMB INJURY 71 0.0026
240 GASTROOESOPHAGEAL REFLUX DISEASE 209 0.0026
241 FACIAL PAIN 23 0.0026
242 VITAMIN D DECREASED 22 0.0026
243 SHOULDER OPERATION 11 0.0026
244 SCIATICA 41 0.0026
245 OROPHARYNGEAL PAIN 238 0.0026
246 FAECES HARD 10 0.0026
247 EPISTAXIS 191 0.0026
248 PROSTATOMEGALY 10 0.0025
249 DEVICE BREAKAGE 103 0.0025
250 PAROSMIA 19 0.0025
251 POSTOPERATIVE WOUND INFECTION 17 0.0025
252 DIVERTICULUM INTESTINAL 11 0.0025
253 NO ADVERSE EVENT 455 0.0025
254 HEART RATE ABNORMAL 14 0.0025
255 MELANOCYTIC NAEVUS 11 0.0025
256 ONYCHOMYCOSIS 11 0.0025
257 BLOOD SODIUM DECREASED 47 0.0025
258 FOOT FRACTURE 47 0.0025
259 FAECES SOFT 18 0.0025
260 INTENTIONAL DOSE OMISSION 70 0.0025
261 MENINGITIS ASEPTIC 11 0.0024
262 DERMATITIS ATOPIC 129 0.0024
263 KIDNEY INFECTION 48 0.0024
264 INITIAL INSOMNIA 25 0.0024
265 FOOT OPERATION 12 0.0024
266 BACK DISORDER 39 0.0024
267 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 115 0.0024
268 DYSPHONIA 140 0.0024
269 POST-TRAUMATIC STRESS DISORDER 16 0.0024
270 MUSCULOSKELETAL DISCOMFORT 41 0.0024
271 ARTHRITIS INFECTIVE 11 0.0024
272 ASTHENOPIA 13 0.0024
273 BLOOD IRON DECREASED 28 0.0024
274 ANHEDONIA 62 0.0024
275 PLEURISY 14 0.0024
276 ORAL CANDIDIASIS 31 0.0024
277 ECZEMA 123 0.0023
278 STREPTOCOCCAL INFECTION 13 0.0023
279 HOSPICE CARE 23 0.0023
280 CONCUSSION 18 0.0023
281 CARDIAC FLUTTER 15 0.0023
282 POOR VENOUS ACCESS 24 0.0023
283 TASTE DISORDER 47 0.0023
284 OXYGEN SATURATION DECREASED 130 0.0023
285 HYSTERECTOMY 20 0.0023
286 MIGRAINE 220 0.0023
287 HUMERUS FRACTURE 11 0.0023
288 SENSITIVITY TO WEATHER CHANGE 12 0.0023
289 BLOOD PRESSURE ABNORMAL 45 0.0023
290 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 118 0.0023
291 HYPERLIPIDAEMIA 27 0.0023
292 EXERCISE TOLERANCE DECREASED 13 0.0023
293 INJECTION SITE DISCHARGE 12 0.0022
294 BREATH SOUNDS ABNORMAL 11 0.0022
295 BURSITIS 27 0.0022
296 BRUXISM 12 0.0022
297 INFECTION 322 0.0022
298 FIBROMYALGIA 54 0.0022
299 FUNGAL INFECTION 74 0.0022
300 CHEILITIS 12 0.0022
301 SPINAL DISORDER 21 0.0022
302 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 38 0.0022
303 VASCULAR DEVICE INFECTION 10 0.0022
304 BLOOD MAGNESIUM DECREASED 19 0.0022
305 PNEUMONIA BACTERIAL 20 0.0022
306 PRODUCT SOLUBILITY ABNORMAL 11 0.0022
307 NASOPHARYNGITIS 401 0.0022
308 WRIST FRACTURE 26 0.0022
309 AUTOIMMUNE DISORDER 21 0.0022
310 SKIN FISSURES 42 0.0021
311 IRRITABLE BOWEL SYNDROME 46 0.0021
312 RESTLESS LEGS SYNDROME 39 0.0021
313 INCREASED UPPER AIRWAY SECRETION 11 0.0021
314 CARPAL TUNNEL SYNDROME 30 0.0021
315 NEPHROPATHY 20 0.0021
316 SLEEP DISORDER 151 0.0021
317 CYSTITIS 68 0.0021
318 TIBIA FRACTURE 10 0.0021
319 SARS-COV-2 TEST POSITIVE 28 0.0021
320 OCULAR HYPERAEMIA 100 0.0021
321 FEAR OF INJECTION 15 0.0021
322 CHEST DISCOMFORT 215 0.0021
323 GESTATIONAL DIABETES 10 0.0021
324 ENDOMETRIOSIS 10 0.0021
325 NEPHROLITHIASIS 96 0.0021
326 URINARY TRACT INFECTION 357 0.0021
327 SKIN ATROPHY 12 0.0021
328 INCONTINENCE 22 0.0021
329 THYROID DISORDER 32 0.0021
330 NECK PAIN 116 0.0021
331 BLEPHAROSPASM 13 0.0021
332 TOOTH ABSCESS 21 0.0021
333 JOINT INJURY 44 0.0021
334 INFLUENZA 229 0.0021
335 MAJOR DEPRESSION 15 0.0021
336 GINGIVITIS 11 0.0020
337 VITREOUS FLOATERS 20 0.0020
338 HEAD DISCOMFORT 36 0.0020
339 THROAT TIGHTNESS 55 0.0020
340 BLOOD POTASSIUM DECREASED 61 0.0020
341 PHOTOPHOBIA 38 0.0020
342 SENSATION OF FOREIGN BODY 17 0.0020
343 GOUT 36 0.0020
344 CONTUSION 193 0.0020
345 TRANSIENT ISCHAEMIC ATTACK 67 0.0020
346 DIVERTICULITIS 55 0.0020
347 BACTERIAL INFECTION 37 0.0020
348 HAND FRACTURE 14 0.0020
349 WALKING AID USER 13 0.0020
350 RETCHING 42 0.0020
351 AGEUSIA 49 0.0020
352 THERAPEUTIC RESPONSE SHORTENED 65 0.0020
353 THIRST 35 0.0020
354 DRUG EFFECT LESS THAN EXPECTED 29 0.0020
355 SKIN MASS 13 0.0019
356 OBESITY 31 0.0019
357 CYST 24 0.0019
358 HEPATOMEGALY 19 0.0019
359 ECONOMIC PROBLEM 29 0.0019
360 DYSGEUSIA 142 0.0019
361 DERMATITIS 40 0.0019
362 THERAPY INTERRUPTED 136 0.0019
363 CATARACT 113 0.0019
364 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 341 0.0019
365 ANAL INCONTINENCE 17 0.0019
366 GINGIVAL PAIN 15 0.0019
367 FACIAL PARALYSIS 16 0.0019
368 GLAUCOMA 36 0.0019
369 OSTEOARTHRITIS 79 0.0019
370 DRY MOUTH 151 0.0019
371 HYPOAESTHESIA ORAL 28 0.0019
372 RED BLOOD CELL COUNT DECREASED 53 0.0019
373 NEURALGIA 45 0.0018
374 TINNITUS 85 0.0018
375 CARDIAC PACEMAKER INSERTION 11 0.0018
376 PAPULE 13 0.0018
377 DEVICE LEAKAGE 80 0.0018
378 PNEUMONIA 595 0.0018
379 POLYP 12 0.0018
380 THERMAL BURN 13 0.0018
381 THERAPY CHANGE 18 0.0018
382 SOMNAMBULISM 12 0.0018
383 SKIN HAEMORRHAGE 27 0.0018
384 PETECHIAE 19 0.0018
385 DEAFNESS UNILATERAL 10 0.0018
386 POOR QUALITY SLEEP 39 0.0018
387 ARTERIOSCLEROSIS CORONARY ARTERY 12 0.0018
388 INFUSION RELATED REACTION 120 0.0018
389 ANKLE FRACTURE 28 0.0018
390 UPPER LIMB FRACTURE 36 0.0018
391 RESPIRATORY DISORDER 54 0.0018
392 PARAESTHESIA ORAL 26 0.0018
393 OSTEOPOROSIS 74 0.0018
394 CONCOMITANT DISEASE AGGRAVATED 11 0.0018
395 HEPATIC STEATOSIS 33 0.0018
396 ACUTE RESPIRATORY FAILURE 34 0.0018
397 HYPERSENSITIVITY 328 0.0018
398 EYE DISORDER 58 0.0018
399 RENAL CYST 14 0.0018
400 PSYCHIATRIC SYMPTOM 13 0.0018
401 PERIPHERAL SWELLING 271 0.0018
402 CHOLECYSTECTOMY 20 0.0017
403 BIPOLAR DISORDER 19 0.0017
404 EYE SWELLING 65 0.0017
405 SPINAL FRACTURE 35 0.0017
406 TEMPERATURE INTOLERANCE 18 0.0017
407 DEVICE ISSUE 156 0.0017
408 BLOOD THYROID STIMULATING HORMONE INCREASED 16 0.0017
409 EATING DISORDER 37 0.0017
410 STAPHYLOCOCCAL INFECTION 57 0.0017
411 BLOOD PRESSURE INCREASED 264 0.0017
412 TOOTH FRACTURE 19 0.0017
413 RALES 10 0.0017
414 SKIN WARM 10 0.0017
415 MALIGNANT MELANOMA 23 0.0017
416 FLUID RETENTION 87 0.0017
417 BLOOD CALCIUM INCREASED 15 0.0017
418 KNEE ARTHROPLASTY 36 0.0017
419 HYPERSOMNIA 49 0.0017
420 PRODUCT USE IN UNAPPROVED INDICATION 423 0.0017
421 DYSPNOEA 965 0.0017
422 SALIVARY HYPERSECRETION 17 0.0017
423 BOWEL MOVEMENT IRREGULARITY 13 0.0017
424 DECREASED INTEREST 10 0.0017
425 SCAR 29 0.0017
426 EYE INFLAMMATION 16 0.0017
427 HERPES ZOSTER 96 0.0017
428 CONSTIPATION 364 0.0017
429 INJECTION SITE RASH 51 0.0017
430 INCORRECT PRODUCT ADMINISTRATION DURATION 36 0.0017
431 FATIGUE 1293 0.0017
432 ATELECTASIS 16 0.0017
433 LOCALISED INFECTION 40 0.0017
434 HAEMOPTYSIS 46 0.0016
435 LIQUID PRODUCT PHYSICAL ISSUE 12 0.0016
436 FALL 546 0.0016
437 ARTHRITIS 129 0.0016
438 BACK PAIN 380 0.0016
439 POLLAKIURIA 68 0.0016
440 CARDIAC OPERATION 14 0.0016
441 HEART RATE INCREASED 161 0.0016
442 PIGMENTATION DISORDER 10 0.0016
443 INJECTION SITE SWELLING 124 0.0016
444 DISABILITY 32 0.0016
445 TENDONITIS 25 0.0016
446 MYASTHENIA GRAVIS 13 0.0016
447 ORTHOSTATIC HYPOTENSION 28 0.0016
448 HOT FLUSH 121 0.0016
449 THERAPEUTIC RESPONSE UNEXPECTED 72 0.0016
450 RASH MACULAR 56 0.0016
451 INJECTION SITE DISCOLOURATION 20 0.0016
452 ONYCHOCLASIS 11 0.0016
453 ARTERIOSCLEROSIS 15 0.0016
454 IMMUNE SYSTEM DISORDER 21 0.0016
455 HYPOXIA 56 0.0016
456 HAEMORRHOIDS 31 0.0016
457 LARGE INTESTINE POLYP 11 0.0016
458 FLATULENCE 90 0.0016
459 HEADACHE 995 0.0016
460 COMPLICATION ASSOCIATED WITH DEVICE 23 0.0016
461 ABDOMINAL DISTENSION 165 0.0016
462 EXTRASYSTOLES 11 0.0016
463 OEDEMA 85 0.0016
464 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
465 BONE PAIN 91 0.0016
466 MUSCLE SPASMS 285 0.0016
467 NIGHT SWEATS 50 0.0016
468 NEEDLE ISSUE 45 0.0015
469 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 10 0.0015
470 HERPES SIMPLEX 10 0.0015
471 CHOKING 30 0.0015
472 DENTAL CARIES 17 0.0015
473 CHILLS 180 0.0015
474 DEAFNESS 40 0.0015
475 TRANSFUSION 16 0.0015
476 INJECTION SITE DISCOMFORT 16 0.0015
477 ORAL PAIN 34 0.0015
478 PULMONARY CONGESTION 20 0.0015
479 BLOOD CALCIUM DECREASED 17 0.0015
480 ORAL DISCOMFORT 21 0.0015
481 INJECTION SITE URTICARIA 37 0.0015
482 MACULAR DEGENERATION 18 0.0015
483 ATRIAL FLUTTER 12 0.0015
484 NEUROPATHY PERIPHERAL 143 0.0015
485 MUSCLE STRAIN 13 0.0015
486 VISION BLURRED 206 0.0015
487 HERNIA 29 0.0015
488 ANXIETY 426 0.0015
489 TOOTHACHE 27 0.0015
490 BREAST MASS 10 0.0015
491 FULL BLOOD COUNT DECREASED 30 0.0015
492 HEAD INJURY 47 0.0015
493 TOOTH DISORDER 33 0.0015
494 INSOMNIA 395 0.0015
495 NOCTURIA 18 0.0015
496 BALANCE DISORDER 128 0.0015
497 THERAPY CESSATION 76 0.0015
498 GROIN PAIN 13 0.0015
499 ULCER HAEMORRHAGE 10 0.0015
500 IMMUNODEFICIENCY 22 0.0015
501 BASAL CELL CARCINOMA 23 0.0015
502 PRODUCT PACKAGING ISSUE 14 0.0015
503 SLUGGISHNESS 15 0.0015
504 SMALL INTESTINAL OBSTRUCTION 18 0.0015
505 PLATELET COUNT INCREASED 19 0.0015
506 PRURITUS 560 0.0015
507 PSORIATIC ARTHROPATHY 59 0.0015
508 PHOTOSENSITIVITY REACTION 24 0.0015
509 PROSTATIC SPECIFIC ANTIGEN INCREASED 20 0.0015
510 DROOLING 10 0.0014
511 MEMORY IMPAIRMENT 198 0.0014
512 PULMONARY HYPERTENSION 30 0.0014
513 SKIN DISORDER 48 0.0014
514 FORMICATION 10 0.0014
515 LEUKOCYTOSIS 26 0.0014
516 GAIT INABILITY 48 0.0014
517 ARTHRALGIA 594 0.0014
518 VERTIGO 87 0.0014
519 DEVICE DELIVERY SYSTEM ISSUE 39 0.0014
520 HEART RATE DECREASED 50 0.0014
521 KNEE OPERATION 14 0.0014
522 LIMB DISCOMFORT 44 0.0014
523 RASH PRURITIC 77 0.0014
524 MUSCLE TIGHTNESS 23 0.0014
525 ABDOMINAL DISCOMFORT 238 0.0014
526 FULL BLOOD COUNT ABNORMAL 15 0.0014
527 SOMNOLENCE 284 0.0014
528 PRODUCT USE ISSUE 265 0.0014
529 RIB FRACTURE 29 0.0014
530 DIZZINESS 703 0.0014
531 SWOLLEN TONGUE 44 0.0014
532 PRODUCT SUPPLY ISSUE 10 0.0014
533 SWELLING 131 0.0014
534 ANAPHYLACTIC REACTION 77 0.0014
535 PAIN 856 0.0014
536 APPENDICITIS 13 0.0014
537 INJECTION SITE BRUISING 111 0.0014
538 TUBULOINTERSTITIAL NEPHRITIS 26 0.0014
539 CARDIAC MURMUR 12 0.0014
540 URINARY INCONTINENCE 41 0.0014
541 HYPOTHYROIDISM 44 0.0014
542 LEUKAEMIA 13 0.0014
543 PROCEDURAL PAIN 38 0.0014
544 DEPRESSION 311 0.0014
545 SWELLING FACE 89 0.0014
546 PHARYNGEAL OEDEMA 21 0.0014
547 DEHYDRATION 182 0.0014
548 INCREASED APPETITE 26 0.0014
549 MUSCULOSKELETAL CHEST PAIN 21 0.0014
550 SENSITIVE SKIN 10 0.0014
551 POST PROCEDURAL COMPLICATION 26 0.0014
552 CELLULITIS 68 0.0013
553 HYPOACUSIS 58 0.0013
554 DISCOMFORT 82 0.0013
555 QUALITY OF LIFE DECREASED 18 0.0013
556 DRY SKIN 179 0.0013
557 ROAD TRAFFIC ACCIDENT 56 0.0013
558 HIP FRACTURE 43 0.0013
559 CONDITION AGGRAVATED 406 0.0013
560 DIARRHOEA 857 0.0013
561 WEIGHT DECREASED 370 0.0013
562 DEVICE USE ISSUE 23 0.0013
563 FEELING ABNORMAL 315 0.0013
564 TROPONIN INCREASED 10 0.0013
565 WEIGHT INCREASED 294 0.0013
566 INTERNAL HAEMORRHAGE 15 0.0013
567 HAEMATOCRIT DECREASED 26 0.0013
568 URTICARIA 219 0.0013
569 LUNG DISORDER 64 0.0013
570 OEDEMA PERIPHERAL 159 0.0013
571 DISEASE RECURRENCE 62 0.0013
572 RENAL FAILURE 173 0.0013
573 NIGHTMARE 45 0.0013
574 IRON DEFICIENCY ANAEMIA 12 0.0013
575 DEVICE RELATED INFECTION 20 0.0013
576 INJECTION SITE PRURITUS 87 0.0013
577 PALPITATIONS 152 0.0013
578 PERICARDIAL EFFUSION 30 0.0013
579 RASH ERYTHEMATOUS 62 0.0013
580 GASTROINTESTINAL DISORDER 116 0.0013
581 ATRIOVENTRICULAR BLOCK 10 0.0013
582 HUNGER 18 0.0013
583 LOW DENSITY LIPOPROTEIN INCREASED 10 0.0013
584 BLOOD PRESSURE FLUCTUATION 31 0.0013
585 APHTHOUS ULCER 10 0.0013
586 ASTHENIA 484 0.0013
587 PULMONARY THROMBOSIS 14 0.0013
588 FLANK PAIN 12 0.0013
589 BLOOD PRESSURE DECREASED 85 0.0013
590 INJECTION SITE REACTION 88 0.0013
591 RASH 557 0.0013
592 PSYCHOLOGICAL TRAUMA 11 0.0013
593 DIPLOPIA 33 0.0013
594 PRODUCT SUBSTITUTION ISSUE 73 0.0013
595 GLYCOSYLATED HAEMOGLOBIN INCREASED 32 0.0013
596 ATRIAL FIBRILLATION 123 0.0013
597 BRONCHOSPASM 18 0.0013
598 PNEUMOTHORAX 20 0.0013
599 NERVE INJURY 14 0.0013
600 NAIL DISORDER 11 0.0013
601 ULCER 20 0.0013
602 VENTRICULAR EXTRASYSTOLES 13 0.0013
603 PULMONARY FIBROSIS 24 0.0012
604 WHITE BLOOD CELL COUNT INCREASED 48 0.0012
605 HYPOAESTHESIA 187 0.0012
606 DEVICE FAILURE 19 0.0012
607 THERAPY NON-RESPONDER 56 0.0012
608 GAIT DISTURBANCE 238 0.0012
609 NAUSEA 984 0.0012
610 INJECTION SITE PAIN 381 0.0012
611 MYALGIA 211 0.0012
612 CHROMATURIA 28 0.0012
613 DYSPEPSIA 122 0.0012
614 PRODUCT PHYSICAL ISSUE 25 0.0012
615 PERIPHERAL COLDNESS 17 0.0012
616 PAIN IN JAW 35 0.0012
617 MICTURITION URGENCY 14 0.0012
618 BLOOD CHOLESTEROL INCREASED 57 0.0012
619 THROMBOSIS 98 0.0012
620 LYMPHADENOPATHY 43 0.0012
621 ACCIDENTAL EXPOSURE TO PRODUCT 125 0.0012
622 PAIN IN EXTREMITY 357 0.0012
623 LIVER FUNCTION TEST INCREASED 26 0.0012
624 SPINAL COMPRESSION FRACTURE 10 0.0012
625 BLADDER DISORDER 12 0.0012
626 DEVICE OCCLUSION 17 0.0012
627 PANIC ATTACK 44 0.0012
628 DYSPHAGIA 114 0.0012
629 BRAIN NEOPLASM 11 0.0012
630 BACK INJURY 13 0.0012
631 INTENTIONAL PRODUCT USE ISSUE 104 0.0012
632 NERVOUSNESS 62 0.0012
633 LABORATORY TEST ABNORMAL 35 0.0012
634 SKIN EXFOLIATION 100 0.0012
635 FREQUENT BOWEL MOVEMENTS 32 0.0012
636 CHEST PAIN 219 0.0012
637 GASTROINTESTINAL PAIN 13 0.0012
638 EYELID PTOSIS 12 0.0012
639 ABDOMINAL PAIN UPPER 243 0.0012
640 RENAL INJURY 35 0.0012
641 CHOLECYSTITIS 14 0.0012
642 SKIN DISCOLOURATION 54 0.0012
643 INTRAOCULAR PRESSURE INCREASED 15 0.0012
644 GINGIVAL BLEEDING 16 0.0012
645 INJECTION SITE ERYTHEMA 145 0.0012
646 SQUAMOUS CELL CARCINOMA 11 0.0012
647 DYSSTASIA 34 0.0012
648 BURNING SENSATION 81 0.0012
649 ADRENAL INSUFFICIENCY 14 0.0012
650 JOINT SWELLING 138 0.0011
651 HALLUCINATION 86 0.0011
652 FLUSHING 116 0.0011
653 DYSURIA 42 0.0011
654 HYPERCHOLESTEROLAEMIA 11 0.0011
655 BLOOD TEST ABNORMAL 16 0.0011
656 STOMATITIS 69 0.0011
657 UNEVALUABLE EVENT 86 0.0011
658 DECREASED APPETITE 264 0.0011
659 MUSCULAR WEAKNESS 129 0.0011
660 PRODUCT DOSE OMISSION 74 0.0011
661 NEOPLASM 13 0.0011
662 HYPERTENSION 235 0.0011
663 HYPERTHYROIDISM 16 0.0011
664 GASTRIC ULCER 21 0.0011
665 MALAISE 484 0.0011
666 VISUAL IMPAIRMENT 136 0.0011
667 APATHY 16 0.0011
668 SKIN LESION 30 0.0011
669 CARDIAC DISORDER 102 0.0011
670 UROSEPSIS 10 0.0011
671 INJECTION SITE MASS 40 0.0011
672 WOUND 30 0.0011
673 MASS 15 0.0011
674 RENAL DISORDER 50 0.0011
675 HEART RATE IRREGULAR 24 0.0011
676 PARAESTHESIA 167 0.0011
677 HOSPITALISATION 163 0.0011
678 AMNESIA 69 0.0011
679 TREMOR 176 0.0011
680 PYREXIA 366 0.0011
681 HYPERHIDROSIS 136 0.0011
682 THERAPEUTIC RESPONSE DECREASED 64 0.0011
683 LIP SWELLING 35 0.0010
684 MUSCULOSKELETAL DISORDER 20 0.0010
685 GENERALISED OEDEMA 13 0.0010
686 FEELING JITTERY 20 0.0010
687 RECALLED PRODUCT ADMINISTERED 10 0.0010
688 HIP ARTHROPLASTY 16 0.0010
689 SHOCK 24 0.0010
690 ARTHROPATHY 58 0.0010
691 PAIN OF SKIN 28 0.0010
692 PRODUCT ADMINISTRATION ERROR 21 0.0010
693 FEEDING DISORDER 21 0.0010
694 PULMONARY ARTERIAL HYPERTENSION 15 0.0010
695 HYPOKINESIA 15 0.0010
696 SPEECH DISORDER 54 0.0010
697 VASCULITIS 12 0.0010
698 JOINT STIFFNESS 27 0.0010
699 BLOOD GLUCOSE ABNORMAL 19 0.0010
700 RASH PAPULAR 23 0.0010
701 MUSCLE ATROPHY 13 0.0010
702 PARKINSONISM 10 0.0010
703 PSYCHOMOTOR HYPERACTIVITY 17 0.0010
704 SKIN CANCER 22 0.0010
705 DEPRESSED MOOD 54 0.0010
706 DISTURBANCE IN ATTENTION 55 0.0010
707 COELIAC DISEASE 10 0.0010
708 HYPOPHAGIA 26 0.0010
709 FAECES DISCOLOURED 22 0.0010
710 ABNORMAL DREAMS 28 0.0010
711 COGNITIVE DISORDER 47 0.0010
712 BLOOD URINE PRESENT 19 0.0010
713 POOR QUALITY DEVICE USED 10 0.0010
714 MOUTH ULCERATION 21 0.0010
715 NODULE 13 0.0010
716 EXPIRED PRODUCT ADMINISTERED 33 0.0010
717 ERYTHEMA 204 0.0010
718 BLOOD COUNT ABNORMAL 15 0.0010
719 URINARY RETENTION 33 0.0010
720 LOWER LIMB FRACTURE 19 0.0010
721 MOBILITY DECREASED 71 0.0010
722 INFLAMMATION 51 0.0010
723 GASTRITIS 26 0.0010
724 DRUG INEFFECTIVE 1298 0.0010
725 EMOTIONAL DISTRESS 119 0.0010
726 ERUCTATION 19 0.0010
727 INTESTINAL OBSTRUCTION 37 0.0010
728 TYPE 2 DIABETES MELLITUS 33 0.0010
729 PRODUCT PREPARATION ERROR 20 0.0010
730 HYPOTENSION 195 0.0010
731 HAIR TEXTURE ABNORMAL 13 0.0010
732 IMPAIRED DRIVING ABILITY 11 0.0010
733 SKIN ULCER 25 0.0010
734 PRODUCT AVAILABILITY ISSUE 22 0.0010
735 HAIR COLOUR CHANGES 12 0.0010
736 TOOTH EXTRACTION 12 0.0010
737 EXTRA DOSE ADMINISTERED 39 0.0010
738 FLUID OVERLOAD 14 0.0010
739 VOMITING 452 0.0010
740 INFLUENZA LIKE ILLNESS 79 0.0010
741 WHITE BLOOD CELL COUNT DECREASED 104 0.0010
742 SCRATCH 10 0.0009
743 BLISTER 53 0.0009
744 BLOOD GLUCOSE DECREASED 45 0.0009
745 COORDINATION ABNORMAL 13 0.0009
746 BODY TEMPERATURE INCREASED 19 0.0009
747 ACUTE KIDNEY INJURY 142 0.0009
748 APHASIA 28 0.0009
749 BACTERAEMIA 11 0.0009
750 INJECTION SITE INDURATION 12 0.0009
751 PRURITUS GENERALISED 20 0.0009
752 MUSCULOSKELETAL STIFFNESS 81 0.0009
753 ADVERSE DRUG REACTION 83 0.0009
754 MOOD ALTERED 25 0.0009
755 SEDATION 24 0.0009
756 MULTIPLE FRACTURES 15 0.0009
757 ANKYLOSING SPONDYLITIS 12 0.0009
758 INJECTION SITE NODULE 10 0.0009
759 RESPIRATORY DISTRESS 25 0.0009
760 ILL-DEFINED DISORDER 55 0.0009
761 HEPATIC CIRRHOSIS 17 0.0009
762 GALLBLADDER DISORDER 16 0.0009
763 MUSCLE SPASTICITY 11 0.0009
764 DEMENTIA 25 0.0009
765 ANAEMIA 170 0.0009
766 BLOOD ALKALINE PHOSPHATASE INCREASED 22 0.0009
767 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 63 0.0009
768 REBOUND EFFECT 10 0.0009
769 LOWER RESPIRATORY TRACT INFECTION 40 0.0009
770 HAEMOGLOBIN DECREASED 90 0.0009
771 DERMATITIS ALLERGIC 11 0.0009
772 RESTLESSNESS 32 0.0009
773 PLATELET COUNT DECREASED 93 0.0009
774 SENSORY DISTURBANCE 14 0.0009
775 HYPOKALAEMIA 40 0.0009
776 SEIZURE 100 0.0009
777 PRESYNCOPE 21 0.0009
778 HEPATIC CYTOLYSIS 11 0.0009
779 BLOOD POTASSIUM INCREASED 14 0.0009
780 FEELING COLD 24 0.0009
781 BONE DENSITY DECREASED 27 0.0009
782 MADAROSIS 10 0.0009
783 ELECTROLYTE IMBALANCE 10 0.0009
784 PSORIASIS 112 0.0009
785 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 47 0.0009
786 HALLUCINATION, VISUAL 18 0.0009
787 LETHARGY 49 0.0009
788 GLOSSODYNIA 19 0.0008
789 THERAPEUTIC PRODUCT EFFECT DECREASED 38 0.0008
790 COLITIS 32 0.0008
791 IMPAIRED WORK ABILITY 18 0.0008
792 DYSKINESIA 34 0.0008
793 CARDIAC FAILURE CONGESTIVE 67 0.0008
794 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 169 0.0008
795 HAEMORRHAGE 87 0.0008
796 FEELING HOT 51 0.0008
797 OSTEOMYELITIS 15 0.0008
798 CONTRAINDICATED PRODUCT ADMINISTERED 25 0.0008
799 SEPSIS 92 0.0008
800 EYE HAEMORRHAGE 11 0.0008
801 DYSARTHRIA 31 0.0008
802 CHOLELITHIASIS 27 0.0008
803 JOINT RANGE OF MOTION DECREASED 11 0.0008
804 HALLUCINATION, AUDITORY 13 0.0008
805 IRRITABILITY 49 0.0008
806 ENCEPHALOPATHY 20 0.0008
807 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
808 ABDOMINAL PAIN 189 0.0008
809 PARANOIA 14 0.0008
810 TENDON RUPTURE 10 0.0008
811 PNEUMONITIS 22 0.0008
812 DISORIENTATION 32 0.0008
813 DRUG EFFECT INCOMPLETE 29 0.0008
814 ALOPECIA 156 0.0008
815 COLD SWEAT 14 0.0008
816 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 37 0.0008
817 ABDOMINAL PAIN LOWER 20 0.0008
818 PLEURAL EFFUSION 48 0.0008
819 DIABETES MELLITUS 60 0.0008
820 GASTRIC DISORDER 27 0.0008
821 DRUG INTOLERANCE 76 0.0008
822 MUSCLE TWITCHING 18 0.0008
823 LOSS OF CONSCIOUSNESS 100 0.0008
824 CEREBROVASCULAR ACCIDENT 132 0.0008
825 INCORRECT DOSE ADMINISTERED 177 0.0008
826 PERICARDITIS 13 0.0008
827 LUNG INFECTION 12 0.0008
828 SYNCOPE 77 0.0008
829 PRODUCT QUALITY ISSUE 103 0.0008
830 RHEUMATOID ARTHRITIS 86 0.0008
831 CONFUSIONAL STATE 122 0.0008
832 RENAL IMPAIRMENT 63 0.0007
833 MULTIPLE SCLEROSIS RELAPSE 51 0.0007
834 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
835 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
836 MULTIPLE SCLEROSIS 35 0.0007
837 TACHYCARDIA 65 0.0007
838 MENTAL STATUS CHANGES 20 0.0007
839 PLASMA CELL MYELOMA 28 0.0007
840 BONE DISORDER 13 0.0007
841 HEMIPARESIS 12 0.0007
842 PULMONARY EMBOLISM 67 0.0007
843 NERVOUS SYSTEM DISORDER 22 0.0007
844 SINUS TACHYCARDIA 10 0.0007
845 ERECTILE DYSFUNCTION 18 0.0007
846 THINKING ABNORMAL 13 0.0007
847 INTENTIONAL PRODUCT MISUSE 61 0.0007
848 HAEMATOMA 18 0.0007
849 CORONARY ARTERY DISEASE 21 0.0007
850 PULMONARY OEDEMA 31 0.0007
851 MOOD SWINGS 22 0.0007
852 ABSCESS 11 0.0007
853 MENTAL DISORDER 30 0.0007
854 SUICIDAL IDEATION 63 0.0007
855 CRYING 25 0.0007
856 OFF LABEL USE 602 0.0007
857 MUSCULOSKELETAL PAIN 36 0.0007
858 FRACTURE 13 0.0007
859 LYMPHOCYTE COUNT DECREASED 12 0.0007
860 ARRHYTHMIA 32 0.0007
861 TOOTH LOSS 14 0.0007
862 RECTAL HAEMORRHAGE 29 0.0007
863 MANIA 11 0.0007
864 PALLOR 18 0.0007
865 HEPATIC ENZYME INCREASED 45 0.0007
866 TREATMENT NONCOMPLIANCE 36 0.0007
867 BLOOD UREA INCREASED 11 0.0007
868 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
869 HAEMATOCHEZIA 36 0.0007
870 PRESCRIBED UNDERDOSE 13 0.0007
871 INCORRECT DOSE ADMINISTERED BY DEVICE 17 0.0006
872 SYSTEMIC LUPUS ERYTHEMATOSUS 23 0.0006
873 LYMPHOMA 10 0.0006
874 GASTROINTESTINAL HAEMORRHAGE 54 0.0006
875 PRODUCT PRESCRIBING ISSUE 14 0.0006
876 SKIN IRRITATION 29 0.0006
877 INJECTION SITE WARMTH 13 0.0006
878 ASPARTATE AMINOTRANSFERASE INCREASED 33 0.0006
879 DRUG ERUPTION 11 0.0006
880 MENTAL IMPAIRMENT 15 0.0006
881 DISEASE PROGRESSION 73 0.0006
882 PRODUCT STORAGE ERROR 54 0.0006
883 HEPATIC FUNCTION ABNORMAL 23 0.0006
884 AGITATION 45 0.0006
885 ALANINE AMINOTRANSFERASE INCREASED 37 0.0006
886 PNEUMONIA ASPIRATION 15 0.0006
887 NEOPLASM MALIGNANT 40 0.0006
888 FEAR 16 0.0006
889 BLINDNESS 24 0.0006
890 LIVER DISORDER 26 0.0006
891 EXPOSURE DURING PREGNANCY 36 0.0006
892 IMPAIRED HEALING 19 0.0006
893 PSYCHOTIC DISORDER 17 0.0006
894 SYRINGE ISSUE 10 0.0006
895 DEEP VEIN THROMBOSIS 37 0.0006
896 NEUTROPHIL COUNT DECREASED 23 0.0006
897 UNDERDOSE 41 0.0006
898 ACTIVITIES OF DAILY LIVING IMPAIRED 11 0.0006
899 BLOOD BILIRUBIN INCREASED 15 0.0006
900 PRODUCT COMPLAINT 14 0.0006
901 BLOOD CREATININE INCREASED 36 0.0006
902 PELVIC PAIN 10 0.0005
903 LIVER FUNCTION TEST ABNORMAL 16 0.0005
904 ACCIDENTAL OVERDOSE 20 0.0005
905 RESPIRATORY ARREST 15 0.0005
906 BLOOD GLUCOSE INCREASED 102 0.0005
907 INJECTION SITE HAEMORRHAGE 43 0.0005
908 ANGER 18 0.0005
909 ACNE 40 0.0005
910 PROTEINURIA 10 0.0005
911 CHOLESTASIS 10 0.0005
912 PRESCRIBED OVERDOSE 10 0.0005
913 HYPOGLYCAEMIA 25 0.0005
914 PANCREATITIS 27 0.0005
915 ABNORMAL BEHAVIOUR 20 0.0005
916 PRODUCT PRESCRIBING ERROR 12 0.0005
917 RHABDOMYOLYSIS 21 0.0005
918 MELAENA 11 0.0005
919 ADVERSE EVENT 46 0.0005
920 HEPATIC FAILURE 15 0.0005
921 ANGIOEDEMA 22 0.0005
922 EMOTIONAL DISORDER 15 0.0005
923 FEMUR FRACTURE 15 0.0005
924 INJURY 34 0.0005
925 DEVICE DISLOCATION 21 0.0005
926 DRUG DOSE OMISSION 78 0.0005
927 SKIN BURNING SENSATION 33 0.0005
928 PRODUCT DISPENSING ERROR 10 0.0005
929 EPILEPSY 14 0.0005
930 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
931 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
932 APPLICATION SITE PAIN 10 0.0005
933 WITHDRAWAL SYNDROME 19 0.0005
934 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
935 ABORTION SPONTANEOUS 18 0.0004
936 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 15 0.0004
937 APPLICATION SITE PRURITUS 10 0.0004
938 CARDIAC ARREST 36 0.0004
939 HYPONATRAEMIA 24 0.0004
940 BRADYCARDIA 22 0.0004
941 CARDIAC FAILURE 33 0.0004
942 COLITIS ULCERATIVE 18 0.0004
943 NEOPLASM PROGRESSION 14 0.0004
944 DRUG INTERACTION 63 0.0004
945 HAEMATEMESIS 10 0.0004
946 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
947 ANAPHYLACTIC SHOCK 10 0.0004
948 UNRESPONSIVE TO STIMULI 10 0.0004
949 C-REACTIVE PROTEIN INCREASED 14 0.0004
950 DEATH 328 0.0004
951 AGGRESSION 19 0.0004
952 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 27 0.0004
953 DEVICE USE ERROR 13 0.0004
954 INTERSTITIAL LUNG DISEASE 18 0.0004
955 JAUNDICE 10 0.0004
956 DRUG EFFECT DECREASED 20 0.0004
957 HYPERKALAEMIA 13 0.0004
958 RESPIRATORY FAILURE 27 0.0004
959 LUNG NEOPLASM MALIGNANT 15 0.0004
960 CEREBRAL HAEMORRHAGE 13 0.0004
961 DRUG ADMINISTRATION ERROR 11 0.0004
962 HYPERGLYCAEMIA 13 0.0004
963 RENAL FAILURE ACUTE 15 0.0004
964 VAGINAL HAEMORRHAGE 15 0.0003
965 MYOCARDIAL INFARCTION 60 0.0003
966 MOVEMENT DISORDER 11 0.0003
967 PANCYTOPENIA 19 0.0003
968 GENERAL PHYSICAL HEALTH DETERIORATION 39 0.0003
969 CARDIO-RESPIRATORY ARREST 14 0.0003
970 THROMBOCYTOPENIA 37 0.0003
971 MATERNAL EXPOSURE DURING PREGNANCY 29 0.0003
972 HAEMATURIA 11 0.0003
973 MALIGNANT NEOPLASM PROGRESSION 31 0.0003
974 SEPTIC SHOCK 13 0.0003
975 NEUTROPENIA 40 0.0003
976 DEVICE DIFFICULT TO USE 19 0.0003
977 FEBRILE NEUTROPENIA 19 0.0003
978 PRODUCT ADHESION ISSUE 10 0.0003
979 BREAST CANCER 25 0.0003
980 SUICIDE ATTEMPT 15 0.0002
981 DRUG DEPENDENCE 38 0.0002
982 MEDICATION ERROR 13 0.0002
983 COMA 11 0.0002
984 DRUG DOSE OMISSION BY DEVICE 16 0.0002
985 OVERDOSE 35 0.0002
986 PROSTATE CANCER 13 0.0002
987 DRUG WITHDRAWAL SYNDROME 10 0.0001
988 TOXICITY TO VARIOUS AGENTS 16 0.0001